Atypical Manifestations of Dengue Fever in Children

 

 Buy Article Permissions and Reprints

Abstract

Objective The burden of dengue fever (DF) is increasing rapidly worldwide. Several atypical manifestations of DF are being increasingly reported but there are no clear guidelines on their definition and management. Their timely detection and appropriate management might improve outcomes. We describe here our experience in managing atypical manifestations of DF in children and their outcomes in a teaching hospital in South India.

Methods A retrospective chart review of children (1 month–18 years) hospitalized, between August 2017 and March 2018 with a diagnosis of DF (NS1 antigen or immunoglobulin M antibodies positivity), was done. The clinical details of the atypical manifestations are described.

Results During the study period, 925 children were hospitalized with DF, of which 94 (10.16%) had severe dengue and 2 (0.21%) died. Among the 925 children, 7 (0.75%) had cardiac, 5 (0.54%) had neurological, 5 (0.54%) had hepatic, and 31 (3.3%) had immunological (infection-associated immune dysregulation) manifestations.

Conclusion Most children with atypical manifestations of DF recover with supportive management. There is a need for a clear definition of atypical manifestations so that large prospective multicenter studies on incidence, optimum management, and outcomes can be done.

Publication History

Received: 18 June 2020

Accepted: 21 November 2020

Article published online:
02 February 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 World Health Organization, Regional Office for South-East Asia. Comprehensive Guideline for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. Revised and expanded edition. WHO Regional Office for South-East Asia. Available at: https://apps.who.int/iris/handle/10665/204894 2011: 17-18
  PubMedGoogle Scholar
• 2 Global strategy for dengue prevention and control 2012–2020, WHO international. Publication date: August 2012 ISBN: 9789241504034 WHO reference number: WHO/HTM/NTD/VEM/2012.5
  PubMed
• 3 World Health Organization. Dengue guidelines for diagnosis, treatment, prevention and control: new edition. World Health Organization; Available at: https://apps.who.int/iris/handle/10665/44188 2012: 10-11
  Google Scholar
• 4 van de Weg CA, Huits RM, Pannuti CS. et al. Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances. PLoS Negl Trop Dis 2014; 8 (10) e3214 DOI: 10.1371/journal.pntd.0003214.
  CrossrefPubMedGoogle Scholar
• 5 Pal P, Giri PP, Ramanan AV. Dengue associated hemophagocytic lymphohistiocytosis: a case series. Indian Pediatr 2014; 51 (06) 496-497
  PubMedGoogle Scholar
• 6 Valero N, Mosquera J, Torres M. et al. Increased serum ferritin and interleukin-18 levels in children with dengue. Braz J Microbiol 2019; 50 (03) 649-656
  CrossrefPubMedGoogle Scholar
• 7 Wichmann D, Kularatne S, Ehrhardt S. et al. Cardiac involvement in dengue virus infections during the 2004/2005 dengue fever season in Sri Lanka. Southeast Asian J Trop Med Public Health 2009; 40 (04) 727-730
  PubMedGoogle Scholar
• 8 Wali JP, Biswas A, Chandra S. et al. Cardiac involvement in dengue haemorrhagic fever. Int J Cardiol 1998; 64 (01) 31-36
  CrossrefPubMedGoogle Scholar
• 9 Li Y, Hu Z, Huang Y. et al. Characterization of the myocarditis during the worst outbreak of dengue infection in China. Medicine (Baltimore) 2016; 95 (27) e4051 DOI: 10.1097/MD.0000000000004051.
  CrossrefPubMedGoogle Scholar
• 10 Miranda CH, Borges Mde C, Matsuno AK. et al. Evaluation of cardiac involvement during dengue viral infection. Clin Infect Dis 2013; 57 (06) 812-819
  CrossrefPubMedGoogle Scholar
• 11 Murthy JMK. Neurological complication of dengue infection. Neurol India 2010; 58 (04) 581-584
  CrossrefPubMedGoogle Scholar
• 12 Varatharaj A. Encephalitis in the clinical spectrum of dengue infection. Neurol India 2010; 58 (04) 585-591
  CrossrefPubMedGoogle Scholar
• 13 Jagadishkumar K, Jain P, Manjunath VG, Umesh L. Hepatic involvement in dengue Fever in children. Iran J Pediatr 2012; 22 (02) 231-236
  PubMedGoogle Scholar
• 14 Bhatia V, Bavdekar A, Yachha SK. Pediatric Gastroenterology Chapter of Indian Academy of Pediatrics, Indian Academy of Pediatrics. Management of acute liver failure in infants and children: consensus statement of the pediatric gastroenterology chapter, Indian academy of pediatrics. Indian Pediatr 2013; 50 (05) 477-482
  CrossrefPubMedGoogle Scholar
• 15 Sklar GE, Subramaniam M. Acetylcysteine treatment for non-acetaminophen-induced acute liver failure. Ann Pharmacother 2004; 38 (03) 498-500
  CrossrefPubMedGoogle Scholar
• 16 Soundravally R, Agieshkumar B, Daisy M. et al. Ferritin levels predict severe dengue. Infection 2015; 43: 13-19
  CrossrefPubMedGoogle Scholar
• 17 Bennett TD, Hayward KN, Farris RWD, Ringold S, Wallace CA, Brogan TV. Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients. Pediatr Crit Care Med 2011; 12 (06) e233-e236
  CrossrefPubMedGoogle Scholar
• 18 Raju S, Kalyanaraman S, Swaminathan K, Nisha A, Praisid S. Hemophagocytic lymphohistiocytosis syndrome in dengue hemorrhagic fever. Indian J Pediatr 2014; 81 (12) 1381-1383
  CrossrefPubMedGoogle Scholar